Clinical Trials Browser

Interventional × Carcinoma, Medullary × nintedanib × Clear all

NCT01788982 2020-07-31

Nintedanib(BIBF1120) in Thyroid Cancer

Phase 2 Completed

Thyroid Neoplasms, Carcinoma, Medullary